LENSAR, Inc. (LNSR): Price and Financial Metrics

LENSAR, Inc. (LNSR): $3.23

0.20 (-5.83%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

LNSR Price/Volume Stats

Current price $3.23 52-week high $5.30
Prev. close $3.43 52-week low $1.80
Day low $3.10 Volume 68,586
Day high $3.60 Avg. volume 40,094
50-day MA $3.82 Dividend yield N/A
200-day MA $3.29 Market Cap 36.81M

LNSR Stock Price Chart Interactive Chart >


LENSAR, Inc. (LNSR) Company Bio


LENSAR, Inc. develops laser technologies. The Company provides autoprecision laser and proprietary 3-D imaging, measurement, and guidance system for refractive cataract surgery. LENSAR serves the healthcare industries throughout the United States.


LNSR Latest News Stream


Event/Time News Detail
Loading, please wait...

LNSR Latest Social Stream


Loading social stream, please wait...

View Full LNSR Social Stream

Latest LNSR News From Around the Web

Below are the latest news stories about LENSAR INC that investors may wish to consider to help them evaluate LNSR as an investment opportunity.

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript

LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning, and thank you for your participation. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the call over to Cameron Radinovic of Burns McClellan, Mr. Radinovic, please go ahead. Cameron Radinovic : Thank […]

Yahoo | November 12, 2023

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

ORLANDO, Fla., November 09, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended September 30, 2023 and provided an update on key operational initiatives.

Yahoo | November 9, 2023

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

ORLANDO, Fla., November 02, 2023--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced that the Company’s third quarter 2023 financial results will be released before market open on Thursday, November 9, 2023. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, November 9, 2023 to discuss the financial results and recent corpor

Yahoo | November 2, 2023

A Piece Of The Puzzle Missing From LENSAR, Inc.'s (NASDAQ:LNSR) Share Price

With a price-to-sales (or "P/S") ratio of 0.8x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending very bullish signals at the...

Yahoo | October 11, 2023

Several Insiders Invested In LENSAR Flagging Positive News

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Yahoo | August 18, 2023

Read More 'LNSR' Stories Here

LNSR Price Returns

1-mo -14.10%
3-mo -15.89%
6-mo 48.85%
1-year 13.45%
3-year -54.76%
5-year N/A
YTD -7.98%
2023 18.58%
2022 -50.58%
2021 -17.38%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!